By bridging structural biology, functional mechanisms, and therapeutic perspectives, we provide a unified understanding of P-gp-mediated MDR and offer insights to guide the development of novel strategies to combat drug resistance in cancer therapy. The gene discussed is PGP; the disease is cancer.